Literature DB >> 33392053

Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa.

Naseem Cassim1, Lindi M Coetzee1,2, Deborah K Glencross1,2.   

Abstract

BACKGROUND: The South African National Health Laboratory Service provides laboratory services for public sector health facilities, utilising a tiered laboratory model to refer samples for CD4 testing from 255 source laboratories into 43 testing laboratories.
OBJECTIVE: The aim of this study was to determine the impact of distance on inter-laboratory referral time for public sector testing in South Africa in 2018.
METHODS: A retrospective cross-sectional study design analysed CD4 testing inter-laboratory turn-around time (TAT) data for 2018, that is laboratory-to-laboratory TAT from registration at the source to referral receipt at the testing laboratory. Google Maps was used to calculate inter-laboratory distances and travel times. Distances were categorised into four buckets, with the median and 75th percentile reported. Wilcoxon scores were used to assess significant differences in laboratory-to-laboratory TAT across the four distance categories.
RESULTS: CD4 referrals from off-site source laboratories comprised 49% (n = 1 390 510) of national reporting. A positively skewed distribution of laboratory-to-laboratory TAT was noted, with a median travel time of 11 h (interquartile range: 7-17), within the stipulated 12 h target. Inter-laboratory distance categories of less than 100 km, 101-200 km, 201-300 km and more than 300 km (p < 0.0001) had 75th percentiles of 8 h, 17 h, 14 h and 27 h.
CONCLUSION: Variability in inter-laboratory TAT was noted for all inter-laboratory distances, especially those exceeding 300 km. The correlation between distance and laboratory-to-laboratory TAT suggests that interventions are required for distant laboratories.
© 2020. The Authors.

Entities:  

Keywords:  CD4; HIV; cluster of differentiation 4; distance; immune status; inter-laboratory referral; travel time

Year:  2020        PMID: 33392053      PMCID: PMC7756670          DOI: 10.4102/ajlm.v9i1.1120

Source DB:  PubMed          Journal:  Afr J Lab Med        ISSN: 2225-2002


  14 in total

1.  Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times.

Authors:  Tamer C Inal; Ozlem Goruroglu Ozturk; Filiz Kibar; Salih Cetiner; Selcuk Matyar; Gulcin Daglioglu; Akgun Yaman
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

2.  National coverage of reflex cryptococcal antigen screening: A milestone achievement in the care of persons with advanced HIV disease.

Authors:  N P Govender; D K Glencross
Journal:  S Afr Med J       Date:  2018-06-26

3.  Providing immediate CD4 count results at HIV testing improves ART initiation.

Authors:  Mamsallah Faal; Nicolette Naidoo; Deborah K Glencross; Willem D F Venter; Regina Osih
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

4.  Analysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support.

Authors:  Lindi Marie Coetzee; Naseem Cassim; Deborah Kim Glencross
Journal:  S Afr Med J       Date:  2017-05-24

5.  Performance verification of the new fully automated Aquios flow cytometer PanLeucogate (PLG) platform for CD4-T-lymphocyte enumeration in South Africa.

Authors:  Lindi-Marie Coetzee; Deborah K Glencross
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

6.  Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.

Authors:  Sergio Carmona; Jacob Bor; Cornelius Nattey; Brendan Maughan-Brown; Mhairi Maskew; Matthew P Fox; Deborah K Glencross; Nathan Ford; William B MacLeod
Journal:  Clin Infect Dis       Date:  2018-03-04       Impact factor: 20.999

7.  An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme.

Authors:  Deborah K Glencross; Lindi M Coetzee; Naseem Cassim
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

8.  Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.

Authors:  Lindi-Marie Coetzee; Keshendree Moodley; Deborah Kim Glencross
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

9.  Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.

Authors:  Lindi-Marie Coetzee; Naseem Cassim; Charlotte Sriruttan; Mabatho Mhlanga; Nelesh P Govender; Deborah Kim Glencross
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

10.  Using laboratory data to categorise CD4 laboratory turn-around-time performance across a national programme.

Authors:  Lindi-Marie Coetzee; Naseem Cassim; Deborah K Glencross
Journal:  Afr J Lab Med       Date:  2018-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.